Previous 10 | Next 10 |
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will participate at: Barclays Global Healthcare Conference on March 14, 2023, at the Loews Miami South Beach Hot...
Product Demonstrations from 3Shape, Ackuretta, A-Dec, ACTEON, Convergent Dental, DCI, Dentsply Sirona, DEXIS, Digital Doc, Medit, Planmeca, and SprintRay New Products, Including the CARINA ™ Digital Intraoral Sensors Display of End-to-End 3D Printing Solutions f...
Henry Schein, Inc. (HSIC) Q4 2022 Earnings Conference Call February 16, 2023, 10:00 ET Company Participants Graham Stanley - VP, IR & Strategic Finance Project Officer Stanley Bergman - Executive Chairman & CEO Ronald South - SVP & CFO Conference Call...
The following slide deck was published by Henry Schein, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Henry Schein, Inc. 2022 Q4 - Results - Earnings Call Presentation
Henry Schein ( NASDAQ: HSIC ) issued 2023 earnings per share guidance that is well above the consensus estimate. The dental products company is projecting non-GAAP diluted EPS of $5.25 to $5.42 ($4.98 consensus). However, this excludes amortization expense of acquired intang...
Henry Schein press release ( NASDAQ: HSIC ): Q4 Non-GAAP EPS of $1.21 misses by $0.01 . Revenue of $3.4B (+2.1% Y/Y) beats by $30M . Introduces guidance for 2023 non-GAAP diluted EPS of $5.25 to $5.42 excluding amortization expense of acquired intangible assets, reflec...
Fourth-quarter net sales of $3.4 billion increased 1.2% compared with the fourth quarter of 2021; internal sales increased 5.0% in local currencies when excluding sales of personal protective equipment (PPE) products and COVID-19 test kits and the extra sales week in 2022 Fourth-quarter G...
Henry Schein ( NASDAQ: HSIC ) is scheduled to announce Q4 earnings results on Thursday, February 16th, before market open. The consensus EPS Estimate is $1.22 (+14.0% Y/Y) and the consensus Revenue Estimate is $3.37B (+1.2% Y/Y). Over the last 2 years, HSIC has beaten EPS es...
Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, announced today that its Board of Directors has authorized the repurchase of up to $400 million of shares of the Company's common stock. This ...
Summary Henry Schein's 'resiliency' premium is still well in situ leading into the new year. Shares have caught a bid leading into the firm's full-year numbers. We demonstrate the profitability momentum garnered over recent and long-term periods to date. Net-net, reiterate buy. ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-22 05:00:09 ET Jeff Johnson from Robert W. Baird issued a price target of $92.00 for HSIC on 2024-07-22 03:31:00. The adjusted price target was set to $92.00. At the time of the announcement, HSIC was trading at $70.34. The overall price target consensus is at $8...
Facility Designed To Improve Efficiency, Enable Innovation, and Better Serve Customers; Modernized, 811K Square Foot Facility in Fort Worth Largest in the Company’s Network Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office...
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its second quarter 2024 financial results before the stock market opens on Tuesday, August 6, 2024, and will provi...